5 
To address international recombinant DNA research issues, Dr. Fredrickson 
asked the Committee whether it would be appropriate to form a subcommittee 
for the purpose of preparing an analysis of international activities to 
date with recommendations to the full Committee on appropriate steps for 
achieving common safety standards wherever the use of recombinant DNA 
techniques take place. There were no objections to the formation of such 
a subcommittee, and the following agencies were appointed to serve on it: 
NIH, State, ACDA, USDA, DoD, OSTP, CDC, Commerce, and Justice. 
In closing the meeting. Dr. Fredrickson stated if there were no other 
issues the Committee representatives wished to consider, a report on 
international activities may conclude the Committee's business. 
Respectfully submitted. 
Joseph G. Perpich, M.D., J.D. 
Associate Director for Program 
Planning and Evaluation 
[ 370 ] 
